Biolase tops pct gainer pack on Q2 revenue beat

November 26

13/08/2021 10:07

** Medical device maker's shares  BIOL.O  soar as much as
36.16% to $0.86 premarket 
    ** Stock tops pct gainers pack on Nasdaq before the bell,
second-most actively traded stock  
    ** Co posts Q2 revenue of $9.1 mln, beating Refinitiv IBES
estimates of $8.3 mln, helped by rising demand for its dental
lasers
    ** Co expects Q3 to approach revenue achieved in Q2 and says
it continues to experience high demand for its dental lasers
 urn:newsml:reuters.com:*:nASA02J03
    ** BIOL's U.S. and international revenue increased 167% and
340%, respectively, as more dental practices were operating in
Q2
    ** Stock up ~51% YTD, as of last close 

 (Reporting by Rithika Krishna in Bengaluru)
 ((Rithika.Krishna@thomsonreuters.com;))